Optinose Share Price Today
(NASDAQ: OPTN)

Name: Optinose Share Price Today (NASDAQ: OPTN) - Optinose Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Optinose share price is $9.17 & ₹786.30 as on 26 Mar 2025, 2.30 'hrs' IST

$9.17

Market is closed - opens 7 PM, 26 Mar 2025

View live Optinose share price in Dollar and Rupees. Guide to invest in Optinose stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Optinose, along with analyst recommendations, forecasts, and comprehensive financials.

Optinose share price movements

Today's Low: $9.14
Today's High: $9.22
$9.17
0.33%
Downside
Day's Volatility :0.84%
Upside
0.51%
52 Weeks Low: $4.82
52 Weeks High: $23.55
$9.17
47.49%
Downside
52 Weeks Volatility :79.55%
Upside
61.06%

Optinose (OPTN) Returns

Period	Optinose Inc	Index (Russel 2000)
3 Months	46.32%	0.0%
6 Months	-12.67%	0.0%
1 Year	-58.69%	0.0%
3 Years	-77.19%	-14.9%

Optinose (OPTN) Key Statistics

in dollars & INR

Previous Close	$9.17
Open	$9.14
Today's High	$9.2174
Today's Low	$9.14
Market Capitalization	$92.8M
Today's Volume	$111.4K
52 Week High	$23.55
52 Week Low	$4.815
Revenue TTM	$75.7M
EBITDA	$-18.8M
Earnings Per Share (EPS)	$-4.35
Profit Margin	-41.16%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1050.5%

How to invest in Optinose Stock (OPTN) from India?

It is very easy for Indian residents to invest directly in Optinose from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Optinose stock in both Indian Rupees (INR) and US Dollars (USD). Search for Optinose or OPTN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Optinose or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Optinose shares which would translate to 0.094 fractional shares of Optinose as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Optinose, in just a few clicks!

Returns in Optinose (OPTN) for Indian investors in Rupees

The Optinose stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Optinose investment value today

Current value as on today

₹44,252

Returns

₹55,748

(-55.75%)

Returns from Optinose Stock

₹58,694 (-58.69%)

Dollar Returns

₹2,946 (+2.95%)

Indian investors sentiment towards Optinose (OPTN)

367%

Period: Feb 23, 2025 to Mar 25, 2025. Change in 30 Days versus previous period

Search interest for Optinose Stock from India on INDmoney has increased by 367% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Optinose

FMR Inc
0.71%
Nantahala Capital Management, LLC
0.65%
MVM Partners LLC
0.65%
Rosalind Advisors, Inc.
0.58%
Stonepine Capital Management Llc
0.39%
Kingdon Capital Management LLC
0.25%

Analyst Recommendation on Optinose

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Optinose(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Optinose Stock (OPTN)

What analysts predicted

Upside of 118.1%

Target:

$20.00

Current:

$9.17

Insights on Optinose Stock (Ticker Symbol: OPTN)

Price Movement
In the last 7 days, OPTN stock has moved up by 52.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 20.49M → 20.43M (in $), with an average decrease of 0.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -14.06M → 467.0K (in $), with an average increase of 904.5% per quarter
OPTN vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 95.6% return, outperforming this stock by 154.3%
OPTN vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 116.7% return, outperforming this stock by 193.5%
Price to Sales
ForOPTN every $1 of sales, investors are willing to pay $1.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

OPTN Optinose Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.1M	↑ 4261.11%
Net Income	$-106.7M	↑ 118.11%
Net Profit Margin	-1.5K%	↑ 28676.75%

	FY19	Y/Y Change
Revenue	$34.6M	↑ 390.18%
Net Income	$-108.9M	↑ 2.14%
Net Profit Margin	-314.59%	↑ 1195.08%

	FY20	Y/Y Change
Revenue	$49.1M	↑ 41.83%
Net Income	$-98.3M	↓ 9.74%
Net Profit Margin	-200.2%	↑ 114.39%

	FY21	Y/Y Change
Revenue	$74.7M	↑ 51.99%
Net Income	$-81.7M	↓ 16.96%
Net Profit Margin	-109.37%	↑ 90.83%

	FY22	Y/Y Change
Revenue	$76.3M	↑ 2.18%
Net Income	$-76.4M	↓ 6.44%
Net Profit Margin	-100.16%	↑ 9.21%

	FY23	Y/Y Change
Revenue	$71.0M	↓ 6.93%
Net Income	$-35.5M	↓ 53.55%
Net Profit Margin	-49.99%	↑ 50.17%

	Q2 FY23	Q/Q Change
Revenue	$19.5M	↑ 64.22%
Net Income	$2.6M	↓ 114.08%
Net Profit Margin	13.5%	↑ 170.97%

	Q3 FY23	Q/Q Change
Revenue	$19.8M	↑ 1.9%
Net Income	$-9.3M	↓ 453.92%
Net Profit Margin	-46.88%	↓ 60.38%

	Q4 FY23	Q/Q Change
Revenue	$19.9M	↑ 0.21%
Net Income	$-10.0M	↑ 7.24%
Net Profit Margin	-50.17%	↓ 3.29%

	Q1 FY24	Q/Q Change
Revenue	$14.9M	↓ 25.09%
Net Income	$-14.1M	↑ 41.14%
Net Profit Margin	-94.54%	↓ 44.37%

	Q2 FY24	Q/Q Change
Revenue	$20.5M	↑ 37.7%
Net Income	$-7.6M	↓ 46.11%
Net Profit Margin	-37.0%	↑ 57.54%

	Q3 FY24	Q/Q Change
Revenue	$20.4M	↓ 0.26%
Net Income	$467.0K	↓ 106.16%
Net Profit Margin	2.29%	↑ 39.29%

	FY18	Y/Y Change
Profit	$5.5M	↑ 3280.86%

	FY19	Y/Y Change
Profit	$29.3M	↑ 435.64%

	FY20	Y/Y Change
Profit	$41.6M	↑ 41.79%

	FY21	Y/Y Change
Profit	$65.5M	↑ 57.47%

	FY22	Y/Y Change
Profit	$67.0M	↑ 2.31%

	FY23	Y/Y Change
Profit	$62.4M	↓ 6.95%

	Q2 FY23	Q/Q Change
Profit	$16.9M	↑ 66.5%

	Q3 FY23	Q/Q Change
Profit	$17.6M	↑ 4.24%

	Q4 FY23	Q/Q Change
Profit	$17.6M	↑ 0.09%

	Q1 FY24	Q/Q Change
Profit	$13.6M	↓ 22.98%

	Q2 FY24	Q/Q Change
Profit	$18.5M	↑ 36.44%

	Q3 FY24	Q/Q Change
Profit	$18.4M	↓ 0.74%

	FY18	Y/Y Change
Operating Cash Flow	$-91.8M	↑ 157.54%
Investing Cash Flow	$-1.7M	↓ 29.76%
Financing Cash Flow	$59.6M	↓ 74.77%

	FY19	Y/Y Change
Operating Cash Flow	$-90.8M	↓ 1.09%
Investing Cash Flow	$-557.0K	↓ 67.04%
Financing Cash Flow	$37.5M	↓ 37.01%

	FY20	Y/Y Change
Operating Cash Flow	$-86.2M	↓ 5.08%
Investing Cash Flow	$-546.0K	↓ 1.97%
Financing Cash Flow	$83.8M	↑ 123.32%

	FY21	Y/Y Change
Operating Cash Flow	$-76.9M	↓ 10.75%
Investing Cash Flow	$-62.0K	↓ 88.64%
Financing Cash Flow	$43.3M	↓ 48.31%

	FY22	Y/Y Change
Operating Cash Flow	$-67.7M	↓ 12.07%
Investing Cash Flow	$-63.0K	↑ 1.61%
Financing Cash Flow	$51.4M	↑ 18.73%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.5M	↑ 19.66%
Investing Cash Flow	$-79.0K	↑ 0.0%
Financing Cash Flow	$-1000.0	↓ 100.62%

Optinose Technicals Summary

Sell

Neutral

Buy

Optinose is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Optinose (OPTN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Optinose Inc	62.3%	-12.67%	-58.69%	-77.19%	-84.72%
Intra-cellular Therapies, Inc.	2.43%	77.09%	95.6%	114.22%	732.49%
Haleon Plc Spon Ads	-1.08%	-5.19%	19.38%	35.49%	35.49%
Zoetis Inc.	-2.43%	-15.78%	-2.64%	-14.82%	44.31%
Neurocrine Biosciences Inc.	-2.46%	1.42%	-17.7%	24.14%	31.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Optinose Inc	NA	NA	NA	-2.99	-10.5	-0.1	NA	-4.09
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	25.1	25.1	1.83	0.37	0.09	0.05	0.02	1.79
Zoetis Inc.	29.49	29.49	2.88	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	35.31	35.31	0.27	6.36	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Optinose Inc	Buy	$92.8M	-84.72%	NA	-41.16%
Intra-cellular Therapies, Inc.	Buy	$14.0B	732.49%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$46.0B	35.49%	25.1	12.84%
Zoetis Inc.	Buy	$73.1B	44.31%	29.49	26.86%
Neurocrine Biosciences Inc.	Buy	$11.6B	31.22%	35.31	14.49%

About Optinose

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Organization	Optinose
Employees	132
CEO	Dr. Ramy A. Mahmoud M.D., M.P.H.
Industry	Health Services

Management People of Optinose

Name	Title
Dr. Ramy A. Mahmoud M.D., M.P.H.	CEO & Director
Mr. Michael F. Marino Esq.	Chief Legal Officer & Corporate Secretary
Mr. Paul Spence	Chief Commercial Officer
Mr. P. Terence Kohler	Chief Financial Officer
Mr. Anthony J. Krick	VP of Finance & Chief Accounting Officer
Mr. Jonathan Neely	Vice President of Investor Relations & Business Development
Ms. Karen E. Brophy	Chief Human Resources Officer & VP of Human Resources

Important FAQs about investing in OPTN Stock from India :

What is Optinose share price today?

Optinose share price today stands at $9.17, Open: $9.14 ; Previous Close: $9.17 ; High: $9.22 ; Low: $9.14 ; 52 Week High: $23.55 ; 52 Week Low: $4.82.

The stock opens at $9.14, after a previous close of $9.17. The stock reached a daily high of $9.22 and a low of $9.14, with a 52-week high of $23.55 and a 52-week low of $4.82.

Can Indians buy Optinose shares?

Yes, Indians can invest in the Optinose (OPTN) from India.

With INDmoney, you can buy Optinose at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Optinose at zero transaction cost.

How can I buy Optinose shares from India?

It is very easy to buy Optinose from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Optinose (OPTN) be purchased?

Yes, you can buy fractional shares of Optinose with INDmoney app.

What are the documents required to start investing in Optinose stocks?

To start investing in Optinose, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.